KRT88P and cryohydrocytosis: In our study, we investigated the prevalence of serum HBV-DNA positivity in HBsAg-negative/anti-HBc-positive CHC patients, with or without the presence of antiHBs, and we found that only 1.97% of them exhibited detectable, low-grade, serum HBV-DNA.